Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate. J Clin Gastroenterol 1997 Dec;25(4):682-4

Date

02/06/1998

Pubmed ID

9451687

DOI

10.1097/00004836-199712000-00026

Scopus ID

2-s2.0-0031460362 (requires institutional sign-in at Scopus site)   27 Citations

Abstract

A 16-year-old boy had hyperammonemia and encephalopathy develop after high-dose chemotherapy for acute lymphoblastic leukemia. He was treated successfully with the ammonia-trapping agents sodium benzoate and sodium phenylacetate.

Author List

del Rosario M, Werlin SL, Lauer SJ

Author

Steven L. Werlin MD Emeritus Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adolescent
Ammonia
Antimetabolites
Benzoates
Benzoic Acid
Brain Diseases
Drug-Related Side Effects and Adverse Reactions
Humans
Male
Phenylacetates